Entera Bio Ltd — Quarterly Financial Statistics (NASDAQ:ENTX)

Financials

Cash from operating activities 2.15 M1.47 M1.4 M1.63 M2.5 M 7 M Cash from investing activities 03 0008 00029 K43 K 83 K Cash from financing activities 13 K3.22 M13.34 M-51 K250 K 16.75 M Free cash flow 2.15 M1.46 M1.4 M1.6 M2.46 M 6.92 M

新闻

What Pushed Entera Bio (ENTX) To Rally Nearly 16% After Hours - Entera Bio (NASDAQ:ENTX)

옵코 헬스, H.C. Wainwright의 ’매수’ 등급 재확인

Opko Health stock rating reiterated at Buy by H.C. Wainwright

Entera Bio, 제노 게르마노 이사회 의장 임명

Entera Bio appoints Geno Germano as board chairman

OPKO & Entera, 경구용 PTH 치료제 개발 협력 확대

OPKO and Entera expand collaboration to develop oral PTH treatment

엔테라 바이오, 2026년 1분기 골다공증 치료제 FDA 제출 계획

Entera Bio plans FDA submission for osteoporosis drug in Q1 2026

엔테라 바이오, FDA BMD 평가 지표 충족에 H.C. Wainwright ’매수’ 등급 유지

H.C. Wainwright reiterates Buy rating on Entera Bio stock as FDA qualifies BMD endpoint

경구용 PTH 유사체, 지속적 칼슘 반응 보여